text:
Just spoke with Mark Jackson, who laughed when he picked up the phone and then went sort of silent when I told him he wasn't getting rid of me this easily.
"I'm learning that," Jackson said, before laughing even louder .
It's nine days since Jackson's firing by the Warriors and a day after they concluded their search and replaced him with Steve Kerr. Which is how I began the interview . . .
Q: Your thoughts on the Warriors hiring Kerr? Think he fits what they wanted when they dismissed you?
JACKSON: I have no thoughts either way. Congratulations to him. Wish him the best. He's inherited a great team with a great future.
And they are a championship-caliber team. Wish them nothing but the best.
Q: Do you suspect they wanted Kerr maybe even before they fired you?
JACKSON: I don't pay any attention to that. What are you going to do with that?
Q: Have you read or heard anything that Lacob or Kerr have said the last few days? The Warriors sure are making it clear they're looking for something different.
JACKSON: Haven't read it to be quite honest.
Ultimately, there's no question that they're a very good team. It's documented that they should be a top-seed, documented they should be in the mix for the West, and they're only going to get better.
It's a great team. I wish nothing but the best for them.
Q: As a guy who had a similar path that he's taking now, from the broadcast booth to the Warriors job without coaching experience, do you understand what he's going through? Feel any of that?
JACKSON: From my end to his? For me, he's not just broadcaster going straight into coaching. I played against him, know him, respect him. A first-class guy.
And so it's not because he has no experience and he's gotten the job and he fits that mold of coming straight from the booth.
Just a guy I have respect for and wish him nothing but the best.
People say why didn't I tweet congratulations yesterday, because I tweeted congratulations to Stan Van Gundy. So why not tweet congratulations to Steve Kerr?
And the only reason for that is it could be read different. So I texted him congratulations. I've got respect for him.
It's nothing negative or any feelings that way. I've got respect for him and wish him the best.
Q: You know people read your congratulations for Van Gundy as a semi-sarcastic swipe at the Warriors -- congratulating him for not taking the Warriors job?
JACKSON: Uh, no. No. I was really just congratulating him. It's good for him, he's a good coach and he's got a great opportunity. So I was just congratulating him.
That's what the internet, what Twitter is for, like that, if you use it wisely. It was a way to show support and congratulate him.
One thing I will say I did not . . . Somebody said -- maybe it was you-- that I was wearing the black suit (for Game 7) to say that I was getting whacked.
Q: That was not me. I said it was not about your situation.
JACKSON: Well, somebody said that and it's not true. I wore it because "somebody's getting whacked," meaning the Clippers.
To say "I'm getting whacked?" Why would I do that? It had nothing to do with that.
Q: Yeah, I know you and you weren't going to wear a suit announcing to your team that you thought they were going to lose that game, which would lead to your immediate firing.
JACKSON: That would be silly for me to do that. That's not how I do stuff.
Q: Did you talk to Stan Van Gundy before he made his decision about what happened to you?
JACKSON: No. no. I think everybody knows what happened. I think everybody's well aware. So there's no reason, unless somebody wanted to hear it from the horse's mouth.
Q: You have anything going on with any other teams?
JACKSON: Just sitting by the phone and waiting for a decision on the next move. I'm excited about what lies ahead and just relaxing with the family right now. And it'll play itself out.
Q: As a New Yorker, are you surprised Kerr didn't take the Knicks job?
JACKSON: Didn't really pay much attention to it. I guess the red flag was the delay. And that's the only thing.
That's why I'm probably not surprised. But it worked out in the end for him. He's making a lot of money, going to a great situation, a place that wanted him badly with a championship-caliber team. That's ready to win.
Great decision or him; let's see how it plays out.
Q: Any thoughts about Kerr walking in with a five-for-$25-million deal three years after you got three-for-$6-million or now it's four-for-$8-million?
JACKSON. No. I'm happy for him.
Q: You think you could be a fit for the Knicks' job?
JACKSON: I'm a guy that's totally at peace. That hasn't changed.
When the opportunity presents itself, I'll be coaching or doing something else. I'm totally at peace and fine with waiting for the next move. And that's if I never coach again and that's if I coach again. That hasn't changed.
I will continue to conduct myself and carry myself as consistent as the public has seen, not just for three years but for my entire life.
Q: Curry clearly was vocally supporting you throughout. But now he's saying he's excited by the Kerr hire. Are you OK with that?
JACKSON: If I ever coach again, if I comment about a great point guard or say how I'm excited about coaching another great point guard, I won't be diminishing what I think about Steph and my relationship with him.
I don't take it that way. I'm pulling for him. It was an honor and a privilege to coach him and the guys I coached for three years. I don't look at it that way all.


text:
Video Library
About SCCA Videos
Learn More About SCCA
What is SCCA?
SCCA unites doctors from three world-class institutions, the Fred Hutch, UW Medicine and Seattle Children's, and brings all their expertise under one roof. Most, if not all, the physicians focus on and deal with only one disease, giving them the expertise in that area. The medical oncologists are leading national clinical trials, the surgeons are thought leaders in their group, and they all come together as a team to develop the best plan for each individual patient. The first therapy for cancer patients is the most important, and because of SCCA's clinical trials program and overall expertise, patients can expect to find more treatment options that anywhere else.
SCCA Survival Rates
SCCA patients, in general, have higher survival rates as compared to other medical centers and community hospitals, based on data released from the National Cancer Data Base (NCDB). If cancer does not recur within a five year period, the chances are low that it will return. The study followed patients treated from 1998-2002, and SCCA attained superior five-year survival rates for patients with breast, colon, lung, leukemia, melanoma, lymphoma, myeloma, and prostate cancers. Dr. Byrd attributes the success of SCCA to attracting the best doctors and nurses, holistic treatment of patients, and cutting-edge treatment and research.
Bladder Cancer Videos
View Bladder Cancer Section
Dr. Jonathan Wright
Dr. Jonathan Wright specializes in urologic oncology, treating bladder, prostate, kidney, penile, and testicular cancers. In this video, Dr. Wright talks about treating bladder cancer. When a patient with bladder cancer comes to SCCA they are going to see someone who treats bladder cancer on a daily basis. SCCA is one of the few centers that treat muscle invasive bladder cancer. Bladder cancer is more common than most people realize. It is the 4th most common cancer in men and the 11th in women. Many cases of bladder cancer are not aggressive, low grade, non-invasive cancer that rarely progresses. Muscle invasive bladder cancer, on the other hand, requires more radical treatment that often requires surgical removal of the bladder. SCCA has several techniques for handling removal of the bladder including total reconstruction called a neo bladder. Very few places are doing bladder removal and even fewer are doing them robotically. SCCA is on the leading edge of robotic removal of bladder cancer.
Bone Marrow Transplant Doctor Videos
View all Bone Marrow Transplant Doctors
Dr. Frederick Appelbaum
Dr. Appelbaum is the Executive Director of SCCA. His work centers on the biology and treatment of acute myeloid leukemia. In this video, Dr. Appelbaum characterizes the mission of SCCA as eliminating cancer as a cause of suffering and death. The only way to do this is to create new knowledge. We provide the very best possible care for cancer today and improve therapies for the future. Every year since 2000, reports back to the federal government about bone marrow transplant has put the SCCA at the top in outcomes. We have performed more transplants than any other center in the world.
Dr. Rainer Storb
Dr. Rainer Storb concentrates his research efforts on bone marrow transplantation. Although he works primarily in the lab, he spends two months working with patients at SCCA. In this video, Dr. Storb discusses the history of bone marrow transplantation. In 1965, bone marrow transplantation was in disarray and fraught with setbacks and failures. A breakthrough came with histocompatibility typing that at the time was still very young. Researchers here also found that stem cells could be harvested from the blood rather than the bone marrow. And recently, over the last decade, a technology called the mini-transplant has been developed in Dr. Storb's laboratory that makes transplant possible for elderly patients who might otherwise not be able to get a transplant.
Dr. Marc Stewart
Dr. Marc Stewart is an oncologist and the Medical Director of Seattle Cancer Care Alliance. In this video, he discusses why choosing a center that's involved in research is so important for a cancer patient. The teams at SCCA are pioneers and founders in the field of stem cell transplantation for cancer patients. Stem cell transplant is a very exciting therapy designed at a minimum to prolong life, and best case to cure patients. The SCCA is world class in its ability to perform cancer related research and translate that into patient care.
Bone Marrow Transplant Treatment Videos
View Bone Marrow Transplant Section
Haploidentical and Cord Blood Transplants
Seattle Cancer Care Alliance is pioneering an exciting clinical trial for the roughly 40% of leukemia and lymphoma patients who can't find a successful donor from either their family or world-wide donor lists. Ronni Maestas, haploidentical bone marrow transplant survivor, shares her perspective of the transplant process. Jessie Quinn, cord blood transplant survivor, also shares her story. They advise people who are struggling to find a donor, ""don't give up hope!"" Ronni states that there are now options for those who previously felt like they had run out of options.
Partners in Hope: Bone Marrow Transplant
Brain Cancer Survivor Videos
View Brain Cancer Section
Glioblastoma (Brain) Cancer Survivor Jairo Venegas
Breast Cancer Doctor Videos
View all Breast Cancer Doctors
Dr. Ben Anderson
Dr. Ben Anderson is a surgical oncologist who treats women with breast cancer. In this video Dr. Anderson discusses SCCA's multidisciplinary approach to treating breast cancer. Everyone at SCCA is able to specialize, making everyone at the SCCA Breast Health Clinic ?super breast specialists? and not just cancer specialists. The SCCA is the academic leader in breast health for the Pacific Northwest. Our advantage at SCCA is our multidisciplinary team. Our surgeons, physicians, nurses and staff work together in an integrated way that minimizes the chance of missing disease. Oncoplastic surgery is where we combine techniques used by plastic surgeons for breast lifts and breast cosmesis with cancer surgery. Together, our team has developed cutting edge techniques for working together in the same operating suite, ideal for patients looking to cure their disease and maintain their body image.
Dr. Janice Kim
Dr. Janice Kim is a radiation oncologist who specializes in treating breast cancer. In this video she discusses radiation treatment at SCCA. We know from studies that after surgery there are microscopic cells left behind. Radiation eradicates those cells and reduces the risk of reoccurrence. Our treatment process is designed to be effective and still have minimal impact to the patient. Most of our patients maintain active lifestyles throughout their treatment. The SCCA multi disciplinary approach means that all your treatments are done at one facility making treatment much more convenient for our patients. We take a group approach to reviewing all patient pathology and imaging. The patient team reviews each case weekly to coordinate findings and treatment efforts. Having our entire team under one roof streamlines communication with the team and patient.
Dr. Constance Lehman
Dr. Constance Lehman is the director of imaging at SCCA. In this video she encourages early detection of breast cancer using mammograms. One thing we know is that if we can detect breast cancer early, we can cure it. This is done through aggressive screening using mammography. The challenge we face at SCCA is education and getting every woman to screen for early detection. We have a mobile program in the community and our combined screening and diagnostic mammography program at the Seattle Cancer Care Alliance. Every mammogram is digitally performed by an expert technologist and interpreted by an expert radiologist. Early detection is the key to successfully curing breast cancer.
Dr. David Byrd
Dr. David Byrd is a UW professor of surgery, the section chief of surgical oncology. In this video, he talks about how he focuses on the patient. Dr. Byrd understands the impact on patient lives when given a cancer diagnosis. Everything at SCCA has the patient in mind. From the moment a patient walks into the building, SCCA's treatment teams are there to support patient goals, including follow up plans and survivorship plans. SCCA personalizes treatment plans by taking what is known at an evidence-based level and tailoring it to patient goals.
Dr. V.K. Gadi
Dr. Gadi is a medical oncologist who specializes in caring for women with breast cancer. In this video, Dr. Gadi outlines some of the qualities that makes SCCA unique. The true value at SCCA is research. We integrate new ideas and new ways of thinking about old problems and build on old tools to come up with better outcomes for our patients. To make meaningful impacts on cancer treatment, scientists and physicians are needed. SCCA provides a level of cooperation between researchers and physicians taking care of patients that's not possible at a lot of places. Our multi-disciplinary approach means that all doctors and physicians involved in patient treatment meet to discuss every case and then meet with the patient on that same day.
Dr. Julie Gralow
Dr. Julie Gralow is a medical oncologist who specializes in treating women with breast cancer. In this video she describes SCCA's approach to patient care. According to Dr. Gralow, SCCA understands that you can?t treat patients without taking the time. Because we have so much to offer in terms of education, research and the best clinical tools, we are able to give the patient everything she needs. Patients that seek us out really want to be an active participant in their care and we strive to make them a full-time member of the team. We also want to be there to care for the whole family. You need your whole team behind you and that includes your family support team. We understand that each patient is variable and comes with her own unique background and genetics. We take all her life circumstances, genetics and genetics of the tumor and create an individualized treatment plan that is more specific and less toxic for our patients.
Dr. Shannon Colohan
Breast Cancer Program Videos
View Breast Cancer Section
NOW Clinic for Breast Cancer
The NOW Clinic provides care for newly diagnosed breast cancer patients. NOW stands for Newly Diagnosed Options for Women, but is also for men. The goal is to see patients within 48 hours, to offer reassurance, and help take away the unknown and fear. By the time patients first see their oncologist they'll know what type of breast cancer they have and what their pathology means.
Breast Cancer Care Team
In this video, Dr. VK Gadi describes the five core disciplines involved in managing breast cancer. In general, there are two doctors that you don't meet very often: they are the "what is it?" and "where is it?" doctors--your pathologist and radiologist. And then there are the "doing doctors." The two that go together, the surgeon and the radiation therapist are responsible for the breast and lymph nodes to make sure that whatever disease was once there is completely annihilated by either removing it (by surgery) or zapping it (by radiation). And finally there's the medical oncologist who comes in to eliminate whatever stray cancer cells that may have found their way to other parts of the body.
Breast Cancer Program
This video provides an overview of the Breast Cancer Program at Seattle Cancer Care Alliance. The clinicians at SCCA are specialists that focus only on breast cancer, and are teachers and researchers that often have access to new drugs and regimens not available in other programs. They work as a team in a multidisciplinary way, with input from surgeons, radiation oncologists, medical oncologists, geneticists and plastic surgeons, to provide the best treatment recommendations for each patient.
Breast Cancer Biology, Stages, and Types
Dr. Larissa Korde provides an overview of breast cancer biology, stages, and types. Breast cancer is the growth of abnormal cells in breast. The stages of development are hyperplasia, atypical hyperplasia, non-invasive cancer or carcinoma in situ, and finally invasive cancer. Dr. Korde explains the stages of breast cancer, ranging from Stage 0, a non-invasive cancer, to Stage 4, a cancer that has spread to other organs. Other factors that an oncologist will look at are the receptors that the cancer expresses. Two hormone receptors are estrogen and progesterone, which is treated with hormone therapy. Another receptor is HER2, which treated with HER2 targeted therapy. Triple Negative is a subtype of breast cancer that does not express any of the latter three receptors and is generally treated with chemotherapy. Inflammatory breast cancer is a rare, but aggressive cancer invading the skin tissue
Breast Cancer Treatment Videos
View Treatment Options Section
Dr. Julie Gralow at ASCO 2014
Dr. Gralow discusses new developments in the treatment of breast cancer at ASCO 2014.
T-DM1 for Breast Cancer
Breast Cancer Breakthroughs
Dr. Byrd Discusses the Latest Breakthroughs in Breast Cancer Treatment According to Dr. David Byrd, one major breakthrough in breast cancer treatment is advancement in early detection. Surveillance is getting better resulting in earlier diagnosis, making breast cancer much more curable. He also discusses exciting new therapies that are able to target tumors allowing treatment of specific tumors using agents that use targeted chemotherapy or hormone therapy. Advancements in hormone treatment for breast cancer allow targeted therapy that helps keep tumors that make estrogen from dividing. This breakthrough is less destructive on the body overall with many less side effects. These advancements have had some exciting impact on breast cancer survival rates at SCCA. In general, breast cancer patients are surviving longer and cure rates are much higher at SCCA than at community hospitals. According to the National Cancer Data Base, SCCA's 5 year survival rates, stage for stage, are superior to other programs with small, medium or large cancer facilities.
Breast Cancer Surgery
Dr. Sara Javid Discusses Surgery Options for Breast Cancer Patients There?s a one in eight chance that a woman will have breast cancer in her lifetime. Most who do undergo some type of surgery to remove it. One option available is a lumpectomy, where only the tumor is removed, rather than the entire breast. This is typically followed by a course of radiation to the breast. Dr. Sara Javid, Surgical Oncologist at SCCA, states that after 25 years of follow up, we now know that this procedure is equally safe in terms of survival and recurrence risk of cancer in the breast. SCCA uses a multi disciplinary team approach to treating patients. This gives patients the full picture up front of what to expect and what options are available to them, empowering them to make choices as they move forward with their breast cancer treatment at SCCA.
Breast Cancer: ASCO 2012
Patient Power discusses breast cancer treatments that are making news at ASCO 2012 with Dr. Julie Gralow.
Surgical Options for Breast Cancer
Surgical oncologist, Dr. Kristine Calhoun, talks about the surgical options for breast cancer patients. Generally, most patients will have surgery as part of their breast cancer treatment. Dr. Calhoun breaks down treatment options into two parts -- how to treat the breast (lumpectomy or mastectomy), and treatment of the lymph nodes. She also discusses the different types of lumpectomies and mastectomies and briefly touches on the rates of recurrence post-treatment. .
Wire Localization Procedure
When breast cancers cannot be felt, surgeons depend on wire localization to remove it. In this video, Dr. Kristine Calhoun walks through the process of wire localization. On the day of surgery, a radiologist, with the help of either an ultrasound or mammogram will locate the tumor and insert a guide wire and tape it in place. The wire allows the surgeon to triangulate the location of the tumor, determine where to make the incision, and where to remove tissue.
Sentinel Node Biopsy
A sentinel node is the first lymph node to which breast cancer is likely to spread. In this video, Dr. Kristine Calhoun, discusses when just the sentinel lymph nodes need to be removed and when it's necessary to remove more lymph nodes.
Biological and Targeted Therapies
Dr. VK Gadi is an oncologist who specializes in the treatment of breast cancer. In this video, Dr. Gadi explains how biologic or targeted therapies are designed to to go after specific vulnerabilities that are unique to the cancer. One therapy that Dr. Gadi is particularly excited about is the use of Herceptin for patients who have HER2-positive breast cancer. Herceptin is an monoclonal antibody which binds to the HER2 protein on the outside of a cancer cell. Once bound, it initiates a series of events that lead to the destruction of the cancer cell.
Clinical Studies for Breast Cancer
What is a clinical trial? Dr. VK Gadi addresses common misconceptions about clinical trials. He explains how cancer centers such as SCCA have access to not only phase III clinical trials, but phase I and phase II trials as well. Clinical trials provide access to novel drugs and treatments that are not commonly available. Dr. Gadi also explains how clinical trials are funded and how patients should not be worried about being stuck with the added burden of clinical trial expenses.
Chemotherapy for Breast Cancer
Dr. VK Gadi, a medical oncologist who specializes in caring for women with breast cancer, discusses chemotherapy. He explains that chemotherapy works by killing things are dividing rapidly, which is a characteristic of cancer cells. In most cases chemotherapy is effective at killing cancer cells, however there other cells in the body that divide rapidly, and that's where the toxicities of chemotherapy come in. Dr. Gadi tells how he helps his patients fight toxicities and avoid low white blood cell counts so they can live active, normal lives throughout their treatment.
Endocrine and Hormonal Therapies
Medical oncologists have three tools to fight breast cancer -- chemotherapy, endocrine therapy and hormone therapy. With hormone therapy, there are two strategies to get rid of hormone receptors that help cancer grow. Dr. VK Gadi describes these strategies including blocking the enzyme that turns pre-estrogen to active estrogen with a drug called Tamoxifen. The most serious side effects from treatment with Tamoxifen are blood clots, which occur in 2-3% of women taking the drug. Dr. Gadi discusses early warning indicators for these risks, and tells how he minimizes serious side effects with drugs such as aromatase inhibitors. He shares study results supporting his treatment strategy and points out the benefits to anti-estrogen therapy.
Breast Cancer Treatment
Dr. Larissa Korde discusses the options for treating breast cancer, including surgery, radiation, and systemic therapy. Surgically removing the tumor is one of the most important aspects of treating breast cancer and is almost always recommended. Radiation is used to target and kill any cancer cells that may remain after surgery. Radiation is always recommended after a lumpectomy, but often not recommended after a mastectomy. Following surgery, the local lymph nodes are evaluated--a procedure that's known as a sentinel lymph node biopsy--to see if the cancer has the potential to spread. Systemic therapies include chemotherapy, hormonal, and targeted therapies. Chemotherapy uses medicines to kill rapidly divining cells, but has toxicity and negative side effects. Hormonal therapies use pills to reduce hormone levels or block receptors, reducing the risk of recurrence by up to 50%. Targeted therapies are drugs specifically targeted to one abnormality, the most common of which is Herceptin.
The DIEP Flap Option for Breast Reconstruction
Dr. Shannon Colohan describes the DIEP flap option for breast reconstruction, which is a tissue-based reconstruction technique.
Breast Tissue Expanders for Breast Reconstruction
Dr. Shannon Colohan explains the process for getting breast tissue expanders before getting implants for women who opt for implant-based reconstruction after recovering from breast cancer.
Breast Cancer Radiation Therapy Videos
View Radiation Therapy Section
Radiation Treatment with Calypso
One side effect of exposing the heart to radiation is the increased risk of heart disease in the future. Seattle Cancer Care Alliance has developed a program for left sided breast cancers that can reduce the radiation exposure to the heart. Dr. Christine Fang explains how Calypso accurately tracks the patient's position using a small radio frequency transponder the size of a grain of rice. The SCCA is one of only three centers using this technique with Calypso.
Radiation Treatment with Calypso
Radiation Treatment with Calypso
Dr. Christine Fang discusses treating breast cancer patients using Calypso.
Radiation Treatment for Breast Cancer
Radiation therapy plays an important role in curing breast cancer. It is used to sterilize the breast and surrounding tissues by eradicating any residual cancer cells left behind after complete surgery or chemotherapy. Dr. Janice Kim discusses radiation treatment including common side effects and the rate of recurrences.
Radiation Treatment with Calypso
Dr. Janice Kim, Radiation Oncologist, discusses the Calypso Localization Program at Seattle Cancer Care Alliance. Calypso is a technique that allows radiation oncologists to more effectively deliver radiation treatment while reducing exposure to secondary organs, such as the heart.
Breast Cancer Screening Videos
Learn More About Breast Screening
Mammography and Breast Density
Dr. Janie Lee provides an overview of breast cancer screening recommendations, including considerations for women with dense breasts and new screening technologies.
Breast Cancer Screening with Dr. Larissa Korde
Recommendations for Screening Mammography Dr. Larissa Korde discusses early detection of breast cancer in this KOMO interview. Currently in the United States about one in eight women will develop breast cancer. Many women don?t have the family history or personal risk factors associated with the disease. The American Cancer Society and Seattle Cancer Care Alliance guidelines recommend women begin screening mammography at age 40 and continue annually.
Breast Cancer Screening with Dr. Ben Anderson
Dr. Ben Anderson explains why mammograms are so important. Mammograms are the fundamental tool for finding breast cancer early and it is early detection and treatment that saves lives. Early detectionnot allows women to live longer, it also requires less aggressive therapy techniques that can save the breast and avoid mastectomy. Dr. Anderson also discusses the virtues of digital mammography, and how they use less radiation and have been shown to be superior to analog methods.
Breast Cancer Screening with Dr. Constance Lehman
Breast Cancer Screening with Dr. Julie Gralow
Annual Mammograms for Breast Cancer Screening Mammography is the best screening tool available for detecting breast cancer at its most curable stages. The value of early detection is well known but the percentage of women receiving annual mammograms is declining in recent years. There are several reasons behind the decline; fear, confusion and lack of health insurance. SCCA is working hard to reverse the trend by providing greater mammography information and access to women of all income levels.
BRCA Mutations and Breast Cancer
Dr. Larissa Korde discusses BRCA mutations and breast cancer. There is a lot of focus on understanding genetic predispositions to breast cancer. Some red flags to possible inherited mutations include early onset of breast cancer in women less than age 40, bilateral breast cancer occurring on both sides, and both breast and ovarian cancers occurring in the same family. The most common gene mutations for breast cancer are BRCA1 and BRCA2 mutations. While BRCA mutations are the cause of only 5-10% of breast cancers, women with these mutations have a risk as high as 50-85% of developing breast cancer, and 10-40% of developing ovarian cancer. Women found to have a BRCA mutation can undergo a more aggressive screening program to diagnose cancer at an earlier and more treatable stage, or can consider taking a more proactive approach including prophylactic mastectomy or oophorectomy to reduce their risk.
Breast Cancer Survivor Videos
View More Breast Cancer Survivors
Breast Cancer Survivor Diane Larkin
Breast Cancer Survivor Camille Mills
Breast Cancer Survivor Debra Jarvis
Breast Cancer Survivor Kelly Larkin-Holmes
Breast Cancer Survivor Keum Ja Bae
Breast cancer Survivor Keum Ja Bae discusses being diagnosed with breast cancer. After a darkened spot was found during a routine mammogram, a biopsy confirmed that she had cancer. Her daughter asked a colleague at Columbia Medical School for the best surgeon in the Seattle area, and Dr. Ben Anderson was unanimously recommended. Keum Ja Bae was impressed by every staff member at SCCA, who helped her feel very comfortable and at ease. They were kind, efficient, intelligent, listened to and answered all of her questions, and truly cared about her. She is now on a mission to raise awareness about SCCA and hopes write a book or memoir about her experience.
Cervical Cancer Videos
View Cervical Cancer Section
Cervical Cancer Screening with Dr. Linda Hipps
In this KOMO interview with Kent Phillips, Dr. Linda Hipps of Seattle Cancer Care Alliance tells that the instance of cervical cancer in the United States has decreased by more than 50% over the past 30 years due to the widespread use of pap tests. Women are encouraged to see their healthcare provider on a regular basis beginning at the age of 21.
Cervical Cancer Screening Guidelines with Dr. Linda Hipps
Andrew Schorr, host of Patient Power, discusses new guidelines for the detection of cervical cancer with Dr. Linda Hipps, Director of Pre-Invasive Disease at Seattle Cancer Care Alliance. Dr. Hipps explains that since cervical cancer does not progress rapidly, the annual paps tests are no longer necessary, and she discourages women from being screened before the age of 21. If a pap test returns abnormal results, women should have a colposcopic evaluation to determine if there is evidence of cervical cancer. Dr. Hipps also shares the guidelines for pap smear screenings of women 65 and older.
Cervical Cancer Survivor Emily Wyse
Colon Cancer Doctor Videos
View all Colon Cancer Doctors
Dr. Alessandro Fichera
Dr. Alessandro Fichera is a nationally renowned, board certified colorectal surgeon specializing in minimally invasive and robotic surgery for gastrointestinal cancers. In this video, Dr. Fichera discusses developing specific treatments for specific patients. Treatment of colorectal cancer has become more and more individualized. At SCCA we are able to identify the specific treatment for the specific patient. We no longer just use an approach that is used for everybody. We are becoming more advanced, specialized and complex in the way we treat colorectal cancer. At SCCA, researchers and clinicians work together on the same cases making clinical research part of our treatment procedure.
Dr. Edward Lin
Dr. Edward Lin is a medical oncologist who specializes in treating gastrointestinal cancers. In this video he describes how SCCA strives to better inform patients about their diagnosis and treatment plan, but more importantly, guide them on their treatment 1, 5, and even 10 years from now. This long-term relationship with patients shows just how successful SCCA is at treating cancer and our survival rate is of one of the best in the world. SCCA's physicians are heavily involved in the clinical trials and are constantly searching for new answers and new treatments for patients. Dr. Edward Lin also describes how SCCA is at the frontier of developing the next generation of gastrointestinal and cancer treatments.
Dr. Anthony Back
Dr. Tony Back is a medical oncologist who treats patients with colorectal, esophageal, liver, pancreatic, and stomach cancer. In this video, Dr. Back discusses how doctor and patient communication is about creating a treatment alliance and creating a plan that both can move forward together on. When patients are involved with their care, they more closely follow the treatments and cope with them better because they know that they have a role in determining the care plan. Patients assume that when treating cancer they need to seek out the most technical and advanced resources possible. At Seattle Cancer Care Alliance, we strive to integrate advanced technical resources with the humanistic attributes of being a physician.
Dr. Andrew Coveler
Dr. Andrew Coveler is a medical oncologist who treats cancers of the gastrointestinal system. In this video, Dr. Coveler discusses advances in gastrointestinal treatment at SCCA. ?Cancer treatments are good, but they?re not really good enough? says Dr. Coveler. This is what brought him to SCCA where he has become a gastrointestinal cancer specialist. That level of specialization made possible by SCCA can mean the difference between curable and not curable. We treat the some of the rarest forms of cancers from patients around the world. Over the last ten years, the introduction of new drugs like Herceptin, new surgical techniques and robotic surgery have dramatically improved gastrointestinal cancer survival rates. The team environment at Seattle Cancer Care Alliance brings all of the disciplines together to provide our patients with the best care in the world.
Colon Cancer Treatment Videos
View Treatment Options Section
Dr. Edward Lin at ASCO 2014
Dr. Lin explains how the ADAPT trial may change the way we look at colorectal cancer treatment.
Colon Cancer Treatment with Dr. William Grady
Dr. William Grady discusses treatment for colon cancer. While many people want to ignore colon cancer, it is one of the most common cancer killers in the United States. Early stage cancers that haven?t spread outside the bowel can be treated by surgery alone, while more advanced metastatic cancers that have spread require surgery along with about six months of chemotherapy. The good news is that there are many more treatments available for colon cancer than even five years ago, and patients diagnosed with metastatic colon cancer are living two to three years instead of just a few months.
Colon Cancer Treatment with Dr. Alessandro Fichera
Dr. Alessandro Fichera gives an overview of colon cancer. The majority of colon cancer cases develop from small polyps that become larger and then cancerous. Other pathways are being identified stemming from flat lesions or associated with inflammatory bowel disease, which are more difficult to detect. Regular colonoscopies are vital for early detection, and should occur by age 50 in the general population, or age 40 or earlier by those with a family history or genetic predisposition. The latest advances in treatment for colon cancer include the ability to see better with endoscopy, more effective medical and radiation treatments, and minimally invasive surgery being as effective as open surgery. The five-year cure rate for stage I cancers are 90%, and stage III as high as 70-75%. The key to success is working with a multidisciplinary team and getting the best treatment the first time.
Colon Cancer Treatment with Dr. David Byrd
Dr. David Byrd discusses treatment options for colon cancer. Most patients have surgery to remove their cancer, and chemotherapy to help prevent the cancer from coming back. Cancers that cannot be removed surgically can be controlled with chemotherapy. Biologic therapies are new medicines that attack cancer cells based on their biological features. These are sometimes called target therapies because they target cancer cells and spare normal cells, unlike most conventional chemotherapy. Survival reports from the National Cancer Data Base show that colon cancer patients who receive their first treatment at SCCA fare better compared to patients at other teaching or community hospitals.
Colon Cancer Screening Videos
Learn More About Colon Cancer Screening
Colon Cancer Screening with Dr. Alessandro Fichera
Dr. Alessandro Fichera talks about prevention and early detection of colorectal cancer. Dr. Fichera is a surgeon and Director of Colorectal Surgical Oncology at the University of Washington and SCCA. Dr. Fichera stresses that colon and rectal cancer can be detected early and even prevented through routine colonoscopies. Pre-malignant stage polyps can be found and removed. Current low fiber and high fat diets increase many problems, including promoting colorectal cancers. Everyone should have a colonoscopy by the age of 50. First degree relatives of patients with colorectal cancer or polyps should have a colonoscopy by age 40. Earlier colonoscopies are recommended for individuals with a known mutation for familial polyposis, lynch syndrome, or other genetic predispositions.
Colon Cancer Screening with Dr. William Grady
Dr. William Grady discusses colon cancer screening recommendations. Colon cancer is the second most common cancer killer of men and women, yet is highly preventable through routine colonoscopies. Colon cancer is a disease of aging, so colonoscopies are recommended for individuals by the age of 50. Most colon cancers come from colon polyps, which can be found and removed during a colonoscopy, and almost prevent all colon cancers. Dr. Grady is happy to see individuals becoming more aware of and participating in screening with colonoscopies.
Colon Cancer Screening with Dr. Gabriela Chiorean
Dr. Gabriela Chiorean emphasizes the importance of routine screening for colon cancer, in this KOMO interview with Kent Phillips. Colon cancer is the third leading cause of death in the United States, but only about half of all people over the age of 50 undergo current recommended screenings. Colon cancer screening can save lives! If you are over 50 talk to your doctor about screening, and if you have a family history of colon cancer, start screening earlier and more frequently.
Colon Cancer Survivor Videos
View More Colon Cancer Survivors
Colon Cancer Survivor Mona Coyle
Colon cancer Survivor Mona Coyle discusses being diagnosed with colon cancer in January 2006. After ignoring a decade of symptoms, Mona had her first colonoscopy and was diagnosed with stage IV colon cancer, and had surgery to remove the tumor a week later. A year later her oncologist found a troubling spot on her lungs, and at this point she found the SCCA. Mona felt a positive difference at SCCA and their attitude that they were motivated to beat this, which made a world of difference to her. After two lung surgeries she has no evidence of disease, and is thinking more about life and not taking it for granted. Mona?s gut tells her that she is here today because she went to the SCCA.
Colon Cancer Survivor Anita Mitchell
Colon cancer survivor Anita Mitchell discusses being diagnosed with stage IV colon cancer on February 3, 2005. Anita had been having symptoms and went in for a colonoscopy, where they discovered she had colon cancer and needed to make an appointment immediately and have surgery. Her dad had died of colon cancer, making it even more heartbreaking to tell her kids. Anita and her friends who are nurses researched surgeons to find the very best, and she ended up at SCCA where they discovered she had stage IV cancer with lesions on her liver. Although she was terrified that she would not come out of surgery, Anita read a book about hope that told her not to let anyone give her statistics, because they weren?t hers. She had the best oncologist who told her that he had a plan for her, and if that didn?t work he had another plan. His positive attitude gave her a glimmer of hope, which was all she needed.
Colon Cancer Survivor Barbara Crummins
Colon cancer Survivor Barbara Crummins discusses being diagnosed with colon cancer in January 2006, and her treatment at SCCA. Barbara was in her 40?s and had always been very health conscious. After eating a huge Mexican dinner one evening her stomach hurt and was swollen for four days before she went to see a GI doctor, who sent her to get an MRI. The surgeon who checked her scans told her he was going to stay late and operate because she probably wouldn?t live until tomorrow. Everything happened quickly and she didn?t quite know what was going on until the surgeon was in the next morning to explain that they removed a huge tumor in her colon, a chunk of her liver and 13 lymph nodes. She was given 3-6 months to live. Barbara switched and went to SCCA more treatment. Under the direction of Dr. Sam Whiting, she underwent a treatment plan that involved chemotherapy, along with some ideas she want to incorporate into her treatment plan including acupuncture. Barbara fought to beat her disease every day with a happy attitude, and consciously connected herself to joy.
Endometrial Cancer Videos
View Endometrial Cancer Section
Endometrial Cancer with Dr. Barbara Goff
Penny Legate speaks with Dr. Barbara Goff about endometrial cancer. The vast majority of endometrial cancers are caused by obesity. Dr. Goff explains that diet and exercise are the best prevention for the disease. She describes the treatment and tells about the survivor rate of the roughly 40,000 women diagnosed with ovarian cancer each year.
Gynecologic Cancer Videos
View Gynecologic Cancer Section
Dr. Barbara Goff
Dr. Barbara Goff is a gynecologic oncologist who specializes in caring for women with cervical, endometrial, ovarian, and other gynecologic cancers. In this video, Dr. Goff discusses advancements in gynecologic oncology at SCCA. At SCCA, our gynecologic oncologists perform surgery, administer chemotherapy and help plan radiation, making them the primary care physicians for women with gynecologic cancers. In the last 6 years, the physicians at SCCA have introduced minimally invasive robotic techniques for gynecologic cancer surgery. These techniques use incisions smaller than a thumbnail and allow surgeons to perform complex surgeries with minimal impact to the patients who often return home the day after surgery. We have also seen an explosion in cancer drug therapies, particularly targeted therapies with out disastrous side effects seen with chemotherapy.
Dr. Heidi Gray
Dr. Benjamin Greer
Gynecologic Cancer Prevention with Dr. Barbara Goff
Dr. Barbara Goff, Director of Gynecological Oncology at Seattle Cancer Care Alliance, talks about cervical cancer prevention including pap smear screen and the human papillomavirus (HPV) vaccine. She discusses endometrial cancer prevention, which has very early warning signs. She also discusses ovarian cancer, factors that help prevent the disease, and symptoms that women should watch for.
Head & Neck Cancer Videos
Head & Neck Cancer Section
Dr. Eduardo Mendez
Dr. Eduardo Mendez is an expert in the surgical treatment of head and neck cancers, including minimally invasive robotic surgery of transoral cancers. In this video, he discusses how Seattle Cancer Care Alliance is a referral center for 5 states in the Pacific Northwest and how SCCA's oncology teams have established high expertise on difficult cases that present in the region. He also discusses how minimally invasive surgery allows surgeons at SCCA to access head and neck tumors that would otherwise be inaccessible using common techniques. This means that patients can expect to retain speech and swallowing functions.
Early Symptoms of Throat Cancer
Drs. Eddie Mendez and Neil Futran, both head and neck cancer surgical oncologists, discuss the diagnosis and treatment of throat cancer. Although there has been a rise in tumors associated with Human Papillomavirus (HPV), there is also a better response rate for tumors that are in the back of the throat. Throat cancer can go undetected in early stages because there are less pain receptors in that area, so the first indicators that something is wrong include irritation that lasts more than a few weeks or difficulty swallowing. Because throat cancers affect critical functions such as speech, swallowing and appearance, treatment options are chosen to maximize these functions. Treatment options include surgery, radiation, and chemotherapy.
Oral Cancer Survivor Scott Morris
Scott Morris discusses being diagnosed and treated for oral cancer at SCCA. Scott was initially diagnosed and treated where he lives in Spokane, but was referred to Dr. Neil Futran at the University of Washington Medical Center when he wanted a second opinion on post-surgery recommendations. Scott was impressed with his personalized care from his first phone call with Dr. Futran. Scott was diagnosed at stage IV, and underwent a second tonsillectomy where they found more microscopic cancer. Doctors Futran and Mendez guided him through the challenging decision between his treatment options. Scott was treated with a caring, understanding and warmth by all the staff that he had not before experienced in health care, and has since encouraged five of his friends to get treatment at the University of Washington Medical Center and SCCA.
Leukemia Videos
View Leukemia Section
Dr. John Pagel at ASH 2013
Dr. John Pagel provides an update on the explosion of new targeted biological therapies for treating chronic lymphocytic leukemia (CLL), at the American Society of Hematology (ASH) 2013 Annual Meeting. These new treatments are offering new hope especially to patients with genetic abnormalities that made them more difficult to treat. These new drugs often work as well for high risk patients, possibly with just a shorter duration of remission than those at a lower risk. One example is GA101, a more potent and improved version of the commonly used Rituximab. The majority of CLL treatment is often a combination of therapies, but is evolving to less combinations involving chemotherapy, and more with various biological therapies. Dr. Pagel gave an example of a clinical trial of patients given Rituximab with either a placebo or Idelalisib (GS1101). The study was stopped early due to the overwhelming success, and all placebo patients were switched to Idelalisib.
Dr. Rainer Storb at ASH 2012
In this interview from the 2012 American Society of Hematology (ASH) Annual Meeting Dr. Rainer Storb, a leader in the field of transplants for over 40 years at the Fred Hutchinson Cancer Center, discusses advances in using bone marrow transplant to treat acute myelogenous leukemia (AML). He talks about novel targeted agents such as sorafenib and AC220, which is a kinase inhibitor. Dr. Storb also describes the refinement of transplants to improve recovery. They no longer require the hospitalization of patients. Learn more about these advancements.
Leukemia Survivor Ron Robbecke
Leukemia survivor Ron Robbecke, describes the moment when he knew something was wrong. When he was diagnosed with chronic myeloid leukemia, he felt like his life was over, having lost his wife to the disease years earlier. Ron went to Seattle Cancer Care Alliance and found hope. His treatment included Gleevec, which kept him alive. Listen to Ron's story of survival and motivation.
Lung Cancer Doctor Videos
View all Lung Cancer Doctors
Dr. Renato Martins
Dr. Renato Martins is the medical director for thoracic/head and neck oncology as well as outpatient general oncology and hematology at SCCA. In this video, Dr. Martins discusses making cancer a more manageable chronic disease. The best chance to cure someone is with the initial treatment. Once the disease has returned, a cure is less likely. Where a patient gets their initial treatment is key to their ultimate outcome. Patients that may be considered inoperable elsewhere, maybe considered operable here at SCCA. SCCA's experience and research is resulting in therapies and treatments that are available today at SCCA and that will only be available at other centers in the future. These advances make our objective of turning cancer into a chronic disease so that patients can be treated and still enjoy a high quality of life.
Dr. Michael Mulligan
Dr. Michael Mulligan is the Director of Minimally Invasive Thoracic Surgery and regularly performs and teaches video-assisted thoracic surgery (VATS). In this video, he describes what differentiates SCCA from other institutions. Dr. Mulligan is part of a team that performs more complex airway surgeries than any other insitutuion in the United States. The team also specializes in a variety of minimally invasive surgical techniques, including video assisted and robotic thoracic surgery.
Dr. Douglas Wood
Dr. Douglas Wood is a UW professor and chief of the Division of Cardiothoracic Surgery. In this video he explains why getting treated at a cancer center such as SCCA is so important to outcomes. In many parts of the country, at least half of the patients with lung cancer are operated on surgeons that are not thoracic surgeons. We have found a consistent pattern of improved outcomes in patients that have their lung cancer surgery by thoracic surgeons. There is clear evidence, particularly in lung and esophageal cancer, that hospitals and centers that take care of more patients with these specific cancers have better outcomes both short term and long term.
Dr. Shilpen Patel
Dr. Patel is a radiation oncologist who specializes in the treatment of thoracic cancer, including lung, thymic, and tracheal tumors, gastrointestinal cancers, and chest sarcoma at UW Medical Center and SCCA Proton Therapy. In this video Dr. Patel describes SCCA's approach to treating patients. At SCCA we strive to treat each patient as a member of our family. We pride ourselves in establishing and maintaining long-term relationships with our patients. Because patients who are highly informed have better results, we seek to educate our patients on all the options available. We use a team of physicians, along with the patient; to develop the best individualized therapy available. Our experts specialize in specific tumors and have experience and vast knowledge of years of treatment and know how to help patients succeed.
Dr. Farhood Farjah
Thoracic surgeon, Dr. Farhood Farjah, is inspired by his patients. He and his colleagues at Seattle Cancer Care Alliance take the time to get to know the people they work with and discuss how the treatment will impact their daily lives. Dr. Farjah's is board certified for general surgery, but his clinical focus is entirely on thoracic treatment. He specializes in minimally invasive surgery, which uses a series of small incisions rather than one large one. As a result, recovery time is reduced, patients get out of the hospital faster and experience less pain.
Lung Cancer Screening Videos
Learn More About Screening for Lung Cancer
Dr. Renato Martins
Lung cancer is a leading cause of death among American men and women, but thankfully today we have more treatment options. Dr. Renato Martins tells of a large national trial showing that CT scans that detect small lesions in the lungs before patients become symptomatic can lowering mortality rates by 20%. The standard of care is now to offer screening to patients with a significant past history of smoking. Specific lung cancers have been identified that can behave differently from another, and at SCCA we are now testing 194 different genetic abnormalities that can happen in lung cancer. And for many of those abnormalities we don't have a therapy yet, but for some we do.
Dr. David Madtes (long)
Dr. David Madtes discusses causes, detection, and survival rates of lung cancer. Lung cancer is the leading cause of cancer death in American men and women, responsible for more deaths than breast, pancreatic, prostate and colorectal cancers combined. Ninety percent of lung cancers occur in current or former smokers. Seventy-five percent of lung cancers are detected at advanced stages after growing silently for months or even years before symptoms manifest. By then the cancer has usually spread to other parts of the chest or organs, making treatment difficult and cure almost impossible. Five year survival rates of Stage I lung cancer are 70%, advanced stage is only 5%. This is why screening and early detection is so important. A recent national lung screening trial showed that low-dose CT screening of high risk individuals reduced lung cancer deaths by 20% compared to those who only had chest X-rays.
Dr. David Madtes (short)
Dr. Madtes talks about low-dose CT scans and the benefits of detecting lung cancer early on.
Lung Cancer Surgery Videos
View Lung Cancer Surgery Section
Minimally Invasive Surgery for Lung Cancer Treatment
Dr. Michael Mulligan talks about the benefits of minimally invasive surgery for lung cancer. In recent years there have been improvements in both early detection of lung cancer, as well as surgical techniques for treatment. Traditionally, lung cancer was treated with a thoracotomy, or large incision in the chest where muscles may be divided and ribs removed or spread. New techniques have evolved that allow surgeons to make one-inch or smaller incisions and use high definition cameras and custom design instrumentation to perform the same operation. Patients recover more quickly, have less pain, and tolerate additional therapy, such as chemotherapy or radiation, much better that patients who undergo open surgery.
Thoracic Surgery for Lung Cancer Treatment
Dr. Farhood Farjah describes the different types of thoracic surgery techniques for lung cancer treatment.
Lung Cancer Survival Rate Videos
Learn More About SCCA Survival Rates
Dr. Michael Mulligan on Survival Rates (long)
Today, there is hope for people fighting lung cancer. Dr. Michael Mulligan explains why Seattle Cancer Care Alliance survivor rates are statistically higher than the national average. SCCA has shifted the way they approach treatment, both medically and surgically. While there were only a few options for chemotherapy in the past, today they are designing individualized treatment regimens. SCCA are also using minimally invasive surgical techniques that significantly reduces the time it takes for a patient to recover from surgery.
Dr. Michael Mulligan on Survival Rates (short)
Dr. Michael Mulligan explains why lung cancer survival rates at Seattle Cancer Care Alliance are so good. He describes a broad based, innovative team that has advanced major changes in medical oncology and surgery. They are now able to design a individualized regimen for each patient and use minimally invasive surgical techniques to significantly reduce recovery time.
Lymphoma Videos
View Lymphoma Section
Dr. Ajay Gopal
Dr. Ajay Gopal specializes in treating patients with lymphoma. In this video he discusses how SCCA specializes in immunotherapy, a way to harness the immune system to treat cancer. Stem cell transplantation is an example of immunotherapy. The SCCA currently ranks first in one-year survival for patients receiving stem cell transplants to treat lymphoma. Another method for treating lymphoma is radio immunotherapy. Whole body radiation treatments expose the whole body to radiation whereas radio immunotherapy preferentially targets tumor sites and delivers less radiation to areas not needing treatment.
Dr. Oliver Press
Dr. Oliver Press is a medical oncologist who specializes in treating patients with lymphoma, leukemia, and myeloma. In this video Dr. Press describes some of the new and exciting treatments that are becoming available for patients with lymphoma. Because there because there are 67 varieties of lymphoma, establishing the correct diagnosis at the start is important. At SCCA, the reason we are curing more patients and have better survival rates for patients with lymphoma is because of clinical research. It is very rewarding to watch new discoveries go from cell lines, to mouse models and into people and then become therapies that are very curative for patients with lymphoma.
CAR T-Cell Therapy
Dr. David Maloney discusses his excitement over CAR (chimeric antigen receptor) T-cell therapy, which uses patients' immune cells to fight back against cancer.
Dr. Stephen Smith at ASH 2013
Dr. Stephen Smith discusses advances in treatment for mantle cell lymphoma at ASH 2013. Dr. Smith feels this is a time of increased optimism for patients diagnosed with this rare and aggressive lymphoma that has historically been difficult to treat. Two new drugs were recently approved by the FDA. Revlimid (Lenalidomide) has been approved for patients having had two prior therapies, one including Bortezomib. Arutenib was given a breakthrough designation by the FDA based on its high clinical trial success, and is approved for patients having had one prior therapy. The challenge now is finding how to integrate these new therapies into current treatment regimens, and see results in real-world use that can differ slightly from clinical trials.
Dr. Ajay Gopal at ASH 2012
In this interview from the 2012 American Society of Hematology (ASH) Annual Meeting Dr. Ajay Gopal, discusses a new study which looks into whether radio immunotherapy could be an improvement for patients with advanced lymphomas. He has pursued an approach to deliver targeted radiation by attaching a radioactive isotope to a monoclonal antibody which specifically targets B-cell lymphomas. They have escalated the dose to the maximum safe dose to deliver more radiation to the tumor sites. The trial replaced a standard high dose therapy regimen with target radiation using radio immunotherapy. Dr. Gopal shares the results of the study.
Dr. Oliver Press at ASH 2012
In this interview from the 2012 American Society of Hematology (ASH) Annual Meeting Dr. Oliver Press explains why there is excitement around antibody-drug conjugates (ADC). ADC allows doctors to selectively focus the drug on the cancer cells reducing the amount of drugs required overall. It is a targeted therapy that should cause a better response in the tumor and minimize toxicity for the patient. Within the last few years, chemists have come up with linkers that keep the drug on antibody until they are delivered to the cancer cell. The first successful ADC for lymphoma was brentuximab vedotin, which is now FDA approved and works well with patients who have relapsed with Hodgkin's lymphoma or T-cell lymphoma. Antibody-drug conjugates are now available in the treatment of B-cell lymphoma. It provides a new targeted approach, a more convenient infusion, and reduced side effects.
Melanoma Videos
View Melanoma Section
TIL Therapy for Advanced Melanoma
Dr. Sylvia Lee explains how tumor-infiltrating lymphocyte (TIL) therapy works to treat late-stage melanoma.
Multiple Myeloma Treatment Videos
View Multiple Myeloma Section
Dr. Edward Libby at ASH 2013
Dr. Edward Libby provides an update on multiple myeloma treatment at ASH 2013. Dr. Libby is most excited about the research that's going into monoclonal antibodies for treatment of multiple myeloma. Monoclonal antibodies are relatively non-toxic, but have added to the quality of response in treatment of other diseases such as lymphoma. New trials are being conducted with Daratumumab in combination with Revlimid and Dexamethasone, with remarkable results for patients with relapsed and refractory multiple myeloma. Our understanding of smoldering myeloma is rapidly increasing, and positive results have been seen from beginning treatment at this earlier stage. However, Dr. Libby cautions that there is still much to learn and treatment of smoldering myeloma is not ready for the general world of oncology.
Dr. Damian Green at ASH 2013
Dr. Damian Green discusses the role of transplant in treating myeloma. Autologous stem cell transplant has been an available treatment for a number of years, and while not a lot has changed in transplant research, studies continue to show that it remains a vital part of treatment. New research is being conducted into the use of pretargeted radio immunotherapy as conditioning for transplant, which has been successful with lymphoma and leukemia. The pretargeting allows for an increased dose of radiation without added exposure.
Multiple Myeloma Treatment and Research
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger of Seattle Cancer Care Alliance, and Noopur Raje of Massachusetts General Hospital discuss treatment and research for multiple myeloma with Andrew Schorr from Patient Power. Dr. Raje, who researches drugs that can help with the bone complications of myeloma, states that they are able to decrease the risk of fractures by about 50% with bisphosphonates. She also discusses a clinical trial which uses osteoblasts to promote bone healing. In the more than 20 years that Dr. Bensinger has studied myeloma, he has never been more hopeful about his ability to fight the disease. Proteasome inhibitors such as bortezomib have dramatically changed the landscape. Remissions have lasted longer and patients have lived longer as a result of these drugs. Learn more about advancements in treatment of myeloma.
Understanding a Multiple Myeloma Diagnosis
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Dr. Noopur Raje discuss understanding the diagnosis of multiple myeloma with Andrew Schorr from Patient Power. Dr. Bensinger explains MGUS (monoclonal gammopathy of undetermined significance) and tells about the risk of progression to active myeloma, which is about 1% a year. He also discusses smoldering multiple myeloma, or asymptomatic myeloma. People with this form of the disease have a higher percentage of plasma cells in their blood and bone marrow, and a higher level of M protein in their blood, but they do not have bone disease, kidney disease and are not anemic. Learn more about their risk of progression to active myeloma.
Multiple Myeloma Testing and Personalized Treatment
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Dr. Noopur Raje discuss testing for the treatment of myeloma with Andrew Schorr from Patient Power. With the heterogeneity of the disease, adjusting the drug schedule and combination for the individual patient is the key to treatment efficacy and the control of side effects. Dr. Raje describes the panel of tests used to determine the appropriate individualized treatment regimen.
Stem Cell Transplant for Multiple Myeloma
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. William Bensinger of Seattle Cancer Care Alliance, discusses the treatment of myeloma with stem cell transplant. He describes an autologous transplant, where high doses of drugs such as melphalan to eradicate the myeloma, and outlines the side effects. Dr. Bensinger tells about clinical trials which are trying to determine if transplants as part of the initial therapy or later in the course of disease treatment is more effective.
Limiting Myeloma Treatment Side Effects
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Noopur Raje discuss ways to limit the side effects of treatment for myeloma with Andrew Schorr from Patient Power. Dr. Raje states that the goal is not just to live longer, but to live longer well. Because every patient experiences different side effects from the treatment of the disease, Dr. Raje says the key is communication with your medical team, including nurses. Listen for more tips on managing side effects of myeloma treatment.
Using Kyphoplasty to Help Relieve Myeloma Back Pain
Is the jury still out on the use of kyphoplasty to treat myeloma back pain? In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. William Bensinger describes the kyphoplasty procedure and how it stabilizes the vertebra to deliver pain relief. In this video he takes a question from a who was told that kyphoplasty should not be used in the lower back. Dr. Bensinger explains that is effective in the lower back, and tells what type of doctors typically perform the procedure.
Multiple Myeloma Survivor Videos
View Multiple Myeloma Section
Multiple Myeloma Patient Jamie Parsons
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, multiple myeloma patient Jamie Parsons and his wife Mary Beth Parsons discuss his diagnosis and participation in a clinical trial. They share their reaction to the diagnosis and describe how a support emerges from others who have dealt with myeloma. Mr. Parsons feels blessed to be a part of the first phase of a 16-month clinical trial. He did not experience side effects, and after more than 3 years, he is pleased with results of his monthly tests. He and Mary Beth are full of hope feel that myeloma is a disease to be managed rather than succumbed to.
Multiple Myeloma Patient Panel
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, multiple myeloma patients discuss their diagnosis, treatment, and living well with the disease. Moderator Andrew Schorr asks panelists about the process of dealing with the emotional impact of the diagnosis and communicating with loved ones and doctors. Panelists provide recommendations, such as assembling a team of doctors beyond your oncologist, to find additional support. They share their perspectives on participating in clinical trials.
Myelodysplastic Syndrome (MDS) Videos
View MDS Section
Transplant for MDS Patients
In this interview from the 2011 American Society of Hematology (ASH) Annual Meeting, Dr. Bart Scott talks with Patient Power about Myelodysplastic Syndrome (MDS). He describes the disease and symptoms, including fatigue, shortness of breath, bruising, and increased infections. He also describes the demographic most commonly effected by the condition--Caucasian men, approximately 72 years old. For patients requiring red cell transfusions, several treatments have been FDA approved. Dr. Scott discusses Revlmid, or Lenalidomide, Vidaza, also known as Azacitidine and Decitabine, or Dacogen. Learn how the type of MDS determines the treatment received.
MDS and Anemia
Dr. Janis Abkowitz, President Elect of the American Society of Hematology (ASH), is from Seattle Cancer Care Alliance. She tells about her study of hemoglobin in myelodysplastic syndromes (MDS) resulting in anemia. It has lead to better outcomes for patients with MDS because they are rethinking how the anemia develops and how it should be treated. Listen to her assessment of progress being made in the treatment of MDS.
Ovarian Cancer Videos
View Ovarian Cancer Section
Ovarian Cancer Biology and Facts
Dr. Heidi Gray describes ovarian cancer biology and facts. Ovarian cancer is the 2nd most common gynecologic cancer in the United States, affecting 22,000 - 25,000 women annually. It is less common than other forms of cancer such as breast cancer, but is difficult to treat as it is often diagnosed at a later stage where it has spread outside the ovary. There are not a lot of known risk factors, but approximately 15-20% of ovarian cancer cases are caused by a genetic mutation passed down in families. All women diagnosed with ovarian cancer should undergo genetic counseling and testing for the two most common genetic mutations, BRCA1 and BRCA2 mutations.
Ovarian Cancer Symptoms and Risk Factors
Dr. Heidi Gray describes ovarian cancer symptoms and risk factors. Ovarian cancer is the 2nd most common gynecologic cancer in the United States. Unfortunately the symptoms are nonspecific, such as bloating, mild abdominal pain, or changes with bladder, which are often attributed to other factors before discovering they may have ovarian cancer. As a result most ovarian cancers are diagnosed at a later stage. There is also not a successful screening strategy as few risk factors are known. The most common risk factor is genetics, which causes only 15-20% of ovarian cancer cases. All women diagnosed with ovarian cancer should undergo genetic counseling and testing for known genetic mutations, as they can have a higher risk for other disease such as breast cancer, and to alter family members to be screened.
Ovarian Cancer Treatment
Ovarian Cancer Treatment with Dr. Barbara Goff
In 2011, nearly 22,000 cases of ovarian cancer were diagnosed. Dr. Barbara Goff talks about the impact of the disease on women and how their lives are being extended with longer symptom-free periods. She tells about the effectiveness of aggressive surgery and aggressive chemotherapy against the disease today.
Clinical Trials for Ovarian Cancer
Dr. Heidi Gray discusses participation in clinical trials for ovarian cancer. Ovarian cancer patients at Seattle Cancer Care Alliance are initially screened for eligibility to participate in a clinical trial. Trials range from Phase I trials that look at specific novel agents not available for use in oncology, to Phase III trials which are large national trials comparing a standard treatment to a treatment with additional therapy. Patients are matched to trials that are the right fit for them. It is also important that they have a sense of being part of the greater good, as results are often not known for 3-5 years and participating in trials often involve more intense therapy, monitoring, and more frequent visits.
Ovarian Cancer Survivor Jane Van Voorst
Jan Van Voorst was on vacation when she felt like something wasn't right. What was initially thought to be irritable bowel syndrome, was eventually diagnosed as late stage ovarian cancer. Jan traveled from Bellingham, Washington to Seattle to meet with Dr. Barbara Goff at Seattle Cancer Care Alliance. Jan describes the experience which saved her life. Her prognosis is excellent more than 5 years after the treatment. Hear her inspiring story.
Pancreatic Cancer Doctors Videos
View Pancreatic Cancer Section
Dr. Sunil Hingorani
Dr. Sunil Hingorani runs a translational research program dedicated to uncovering mechanisms of pancreas cancer formation and developing new early detection and treatment strategies. In this video, Dr. Hingorani discusses his motivation for researching pancreas cancer as well as some of the challenges pancreas cancer presents. Pancreas cancer has a tendency to spread early in the course of progression. The result is complications that tend to happen more often than in other types of cancer. Optimal treatment for pancreas cancer involves multiple types of therapies and specialties. SCCA brings the patient and all the specialists into one room at the same time to develop a comprehensive care plan. The SCCA is currently developing new kinds of therapies for cancers that are resistant to existing therapies. At the SCCA, we don?t just treat a disease, we treat people.
Dr. Venu Pillarisetty
Dr. Venu Pillarisetty is a surgical oncologist who cares for patients with pancreas cancer and other gastrointestinal malignancies. In this video Dr. Pillarisetty describes the advances that are happening in the treatment of pancreatic cancer. Currently, pancreatic cancer is the disease that has the least successful treatment and the most potential for improvement through research. Pancreatic cancer cells behave very differently than other cancer cells and have a high probability of spreading to the liver, lung and inside the abdomen. For the first time in years, pancreatic cancer treatment is improving with new advances in chemotherapy, immunotherapy and surgical techniques. At SCCA we are pushing new advancements on each of these fronts.
Dr. James Park
Dr. James Park is a surgical oncologist at the University of Washington Medical Center who works with the pancreas cancer care team at SCCA and the liver tumor clinic at UW Medical Center. In this video, Dr. Park describes what he sees as the two components of the Pancreatic Cancer Specialty Clinic at SCCA. The first is the multi-disciplinary clinic that is run by the collaborative effort of the medical, radiation and surgical oncologists. The second component is where we bring together researchers, physician scientists and those working on translational scientific projects together to try to develop a cure for pancreas cancer. Traditional treatment plans will not produce better outcomes until we can develop better treatment modalities through research. With each case we treat we learn more about this disease which we hope will lead to cures for pancreas cancer.
Pancreatic Cancer Treatments Videos
Pancreatic Cancer Treatment Options
Dr. Andrew Coveler at ASCO 2014
Dr. Coveler discusses the results of a Phase II trial focusing on multi-agent chemotherapy with radiation pre- and post-surgery for pancreatic cancer treatment.
Dr. Gabriela Chiorean Reports from ASCO 2013
Dr. Gabriela Chiorean, a GI medical oncologist, talks with Patient Power about two new therapies for pancreatic cancer patients. The first, a new combination therapy, abraxane plus gemcitabine, is now considered the gold standard for treating patients with metastatic pancreatic cancer. The second is a promising vaccine for pancreatic cancer, called HyperAcute Pancreas, that is aimed at early stage pancreatic cancer patients.
Dr. Sunil Hingorani Reports from ASCO 2013
Dr. Sunil Hingorani, a leader in pancreatic cancer research, explains the unique challenges in treating the disease. He shares the results of a Phase I trial that used PEGPH20 in combination with chemotherapy for patients with pancreas cancer. Dr. Hingorani described the trial as a new way to understand why the tumor is resistant to therapy and was encouraged by the initial results.
Surgery for Pancreatic Cancer
Minimally invasive surgery offers promise for pancreatic cancer patients. Dr. Venu Pillarisetty, Surgical Oncologist at Seattle Cancer Care Alliance, discusses the whipple procedure, which offers the best hope for a cure. Surgery is typically combined with chemotherapy and radiation therapy due to the high recurrence rate. Dr. Pillarisetty explains his laparoscopic or minimally invasive approach to surgery and the impact on recovery and pain management.
Patient Support Videos
View Patient Support Section
Dr. Jesse Fann
Dr. Jesse Fann is a psychiatrist and the Director of the Psychiatry and Psychology Service at SCCA. In this video, Dr. Fann talks about how a the diagnosis and treatment of cancer can lead to significant stress, which can be very overwhelming and lead to symptoms such as insomnia, anxiety and depression. The Psychiatry and Psychology services at SCCA strive to help patients get through treatment as smoothly as possible and get back to doing what they want to do. SCCA addresses the emotional, psychological, emotional and spiritual needs during cancer treatment. Our goal is to help patients continue with their lives during treatment. Our patients enjoy state of the art psychosocial care that is truly integrated into their oncology care. The SCCA provides the best treatment options and the best outcomes for cancer treatment along with comprehensive and compassionate care for the body, mind and spirit.
Shine Retail Store with Dr. Julie Gralow (Long)
Dr. Julie Gralow of Seattle Cancer Care Alliance explains what's unique about Shine retail store. Located on the ground floor of SCCA House, it was designed with a focus on helping patients and loved ones get through cancer. The store offers compression garments, mastectomy bras, sexuality aids and other items in a very private, safe area, where patients can feel comfortable browsing and asking questions. Learn more about the shine store.
Shine Retail Store with Dr. Julie Gralow (Short)
Shine is a new retail endeavor on the ground floor of the Seattle Cancer Care Alliance House. The back of the store was designed for cancer patient to shop for items such as mastectomy bras and compression garments in a private, comfortable environment, where they can ask difficult questions. Watch this short video to learn more.
Patient Support Services
Getting good cancer treatment is not just about getting the right drug. It is about patient support services, including pastoral care, social work, child life, nutritionists and even classes such as yoga and knitting. Listen to doctors and staff at Seattle Cancer Care Alliance tell about the services available to patients and their families to improve their treatment experience. It's the little things that make the difference when providing better care.
Pediatric Cancer Videos
Learn More About Pediatric Cancer Treatment
Dr. Julie Park
Dr. Julie Park specializes in caring for children with neuroblastoma and non-Hodgkin's lymphoma. In this video Dr. Park discusses the unique challenges of treating children. Children bring a different aspect to how you care for patients. Children recover faster than adults and they come with parents and siblings. If the family can't function, then it becomes very difficult to treat the child. The resources available at the Seattle Cancer Care Alliance for families include social work to help families, child life specialists to help families cope and nutritionists.
Bone Marrow Transplant for Children
Leukemia Survivor Danel Lawrence
Prevention Videos
Prostate Cancer Doctor Videos
View all Prostate Cancer Doctors
Dr. Bruce Dalkin
Dr. Bruce Dalkin Describes the Importance of Selecting the Right Treatment Center for Prostate Cancer Dr. Bruce Dalkin is a urologic oncologist with 20 years of experience in the diagnosis and treatment of bladder and prostate cancer. In this video he discusses how where you get your cancer treatment does matter. When considering radiation technology, surgery or even treatment for cancer spread, survival is based on the provider. SCCA has nearly 15 physicians focused on treating prostate cancer , which makes it a unique place.
Dr. Celestia Higano
Dr. Celestia Higano is a medical oncologist who specializes in treating prostate cancer. In this video, she discusses why SCCA is one of the top facilities in the country for treating prostate cancer. This is demonstrated by SCCA's selection to the Department of Defense prostate clinical trials consortium. SCCA is also one of 11 institutions that have a SPORE (Specialized Programs of Research Excellence) grant in prostate cancer.
Dr. Robert Bruce Montgomery
Dr. Bruce Montgomery is clinical director of genitourinary medical oncology, carrying out research and seeing men and women with genitourinary cancers at SCCA/UWMC. In this video, Dr. Montgomery describes his approach to treating men with prostate cancer, which is to make sure that the man he's talking to knows as much about his disease as possible, so that together they can come to a decision on a treatment plan.
Dr. Jonathan Wright
Dr. Jonathan Wright specializes in urologic oncology, treating bladder, prostate, kidney, penile, and testicular cancers. In this video, Dr. Wright talks about treating bladder cancer. When a patient with bladder cancer comes to SCCA they are going to see someone who treats bladder cancer on a daily basis. SCCA is one of the few centers that treat muscle invasive bladder cancer. Bladder cancer is more common than most people realize. It is the 4th most common cancer in men and the 11th in women. Many cases of bladder cancer are not aggressive, low grade, non-invasive cancer that rarely progresses. Muscle invasive bladder cancer, on the other hand, requires more radical treatment that often requires surgical removal of the bladder. SCCA has several techniques for handling removal of the bladder including total reconstruction called a neo bladder. Very few places are doing bladder removal and even fewer are doing them robotically. SCCA is on the leading edge of robotic removal of bladder cancer.
Prostate Cancer PSA Videos
More About PSA Screening
PSA Screening (1)
The Importance of Regular Prostate Screening Prostate cancer is the most common cancer diagnosis in men today. One in six men in their lifetime will be diagnosed with prostate cancer. The best method of early detection is screening. Talk to your doctor about prostate cancer screening--that includes a rectal exam where we feel the prostate through the rectum, and a PSA or a prostate-specific antigen blood test. There are a lot of reasons why a man might have an elevated PSA and cancer is just one of them. We use the PSA test to figure out what a person's risk is for prostate cancer.
PSA Screening (2)
The Importance of Regular Prostate Screening In early prostate cancer there are no symptoms. A simple detection method is the prostate specific antigen (PSA) blood test. Any healthy man under the age of 65 can benefit from early prostate cancer detection. In general, men over 50 years of age should be screened annually; men with a family history of prostate cancer and African Americans should start screening earlier, generally at 40 years.
A Place for the PSA Test
Dr. Daniel Lin, Chief of Urologic Oncology, discusses the recent controversy about PSA screening for colon cancer, following negative recommendations by the United States Preventative Services Task Force (USPSTF). Dr. Lin feels it was a premature recommendation to stop PSA screening, but rather should have called for no automatic or routine PSA screening in every man. He believes the decision should be made on an individual basis between a man and his doctor, based on his personal situation and risk factors. Dr. Lin does recognize points in the USPSTS study that have merit, including the concern of over treating men with low-grade or slow-growing tumors. He feels it is important to unlink diagnosis with treatment, and learn to screen smarter such as with less frequency, by developing new biomarkers and embracing active surveillance over treatment in about half of the cases. Dr. Lin also discusses some of the issues with the two major screening trials that he feels skewed the results.
Prostate Cancer Treatment Videos
View Prostate Cancer Section
Prostate Cancer Treatment at SCCA
The best options for prostate cancer treatment in the United States can be found at SCCA. The physicians and researchers focus on one area, helping them to know everything about that disease and how treatments can be personalized. The SCCA prostate program is multidisciplinary and combined expertise on both the clinical and research sides create multiple areas of insight for every patient. More options increase the likelihood to prolong and create a better quality of life. Evidence is clear that it matters where you get your treatment, that survival is based on the provider. SCCA sets the standard care for the nation, and is a step ahead of what community cancer centers or physicians can offer in terms of insight, experience, education, and novel treatments.
Prostate Cancer Survivor Videos
View Prostate Cancer Section
Prostate Cancer Survivor Rob Wilkinson
Rob Wilkinson considered himself healthy until he was diagnosed with prostate cancer, which registered a Gleason score of 9 out of 10. He shares how he found ""extraordinary care"" through the Seattle Cancer Care Alliance and the prostate cancer was contained. With a bright future ahead, Rob says having battled the disease has made him a better person. He has since recommended Seattle Cancer Care Alliance to a family member who also had his prostate removed.
Sarcoma Videos
View Sarcoma Section
Sarcoma Program at SCCA
Drs. Robin Jones and Darin Davidson discuss the sarcoma program at Seattle Cancer Care Alliance. Dr. Davidson explains that sarcoma affect connective tissue such as bone, muscle, fat, blood vessels and nerves. Dr. Jones says that there are about 70 known sub-types of sarcoma with their own clinical behavior, biology and response to systemic treatment. He explains how a team of doctors at SCCA review the pathology and radiology of each patient to formulate individualized treatment plans.
Dr. Robin Jones at ASCO 2014
Dr. Jones discusses recent clinical studies and long-term disease-control outcomes for sarcoma.
Leiomyosarcoma Survivor Warren Bailey
Sarcoma Survivor Rebecca Greenway
Testicular Cancer Survivor Videos
View Testicular Cancer Section
Testicular Cancer Survivor Scott Whitman
UW-OncoPlex Videos
View UW-OncoPlex Section
UW-OncoPlex at SCCA
University of Washington Onco-Plex introduces a more precise way of choosing the most effective treatment for cancer patients. Dr. Colin Pritchard explains how. He tells about finding what makes each cancer unique in order to target the cancer's "Achilles heel" with treatment.

subset: commoncrawl


text:
Download and run the remover rmsircam.com on the infected computer.
Restart the computer, run AVG and delete all infected files.
I-Worm.Sircam.A is an Internet and network virus similar to I-Worm.Magistr.A This worm spreads through email using its own SMTP routine, sending itself to addresses from the Address Book and from cache or to the list of shared directories.
Need to remove another specific virus?
Return to our Virus Removal page to select another virus removal tool.


text:
Error while retrieving the data (Error Code: MBTo_500_1MBBa_INVALID_STATUS)
Expert Fantasy Advice
Big Board: Ranking Fantasy Football's top 50 assets
Receivers lead the way atop Brandon Funston's initial rankings heading into the start of training camps. … More »
Outfielder Shuffle Up: The ageless Carlos Beltran
There's plenty wrong with the Yankees offense this year, but Carlos Beltran is part of the solution. … More »
Freak Show Podcast: Cardinals pen, Strasburg and Giolito, Steven Wright
Brandon Funston and Scott Pianowski talk MLB news and happenings, starting in St. Louis. … More »
Daily Dime: Hanley Ramirez, Kershaw and Cueto, Coors Field
Hanley Ramirez's bat has come alive this week and he's cheaply priced for Sunday DFS. … More »
Mostly MLB Notes: Talking Encarnacion and a look around the league
Talking Edwin Encarnacion, a look around the league and other random nonsense. … More »


text:
About the Book
"Hollister Rand's ability to deliver messages is compassionate, yet educational. Whether in person, on radio, TV, or in this book...she delivers."
—John Edward, author of Infinite Quest
Psychic medium Hollister Rand is a magnet for opinionated young people who have lots to say—even after death. In I'm Not Dead, I'm Different, she shares with readers the uplifting and enlightening wisdom she has gained from the spirits of children taken from the earthly plane before their time, wisdom that far surpasses their years on Earth. Readers of John Edward, Sylvia Browne, Alison Dubois, and Conchetta Bertoldi will immediately recognize the worth in the guidance offered by these departed young ones, and anyone seeking solace or answers after the loss of a loved one will find great comfort in I'm Not Dead, I'm Different.
Rand was initially puzzled as to why young spirits wanted to speak through her—she had no children of her own and the responsibility of talking with people who had lost theirs seemed too great to bear. But the compelling answers came with time and patience: No one finds death more inexplicable than a grieving parent, thus no spirits are more motivated to make sense of it all for those they've left behind than young ones. These spirits clearly want to heal broken hearts and deepen our understanding of life and death, and Rand has the unique ability to help deliver their messages.
Through her, young spirits talk freely about how to make sense of murder, suicide, and accidental deaths. They also discuss the different ways relationships on both sides can be mended, how the intergenerational cycle of abuse and addiction can be stopped, and how "joy guides"—miscarried and aborted children—can actually help those they've left behind move forward.
The insights they share in this uniquely comforting book will surprise, inform, and inspire. What's more, their answers to our questions about death reveal many valuable tips for living a better life while on earth too.
Educator and Librarian Resources
Product Details
- Imprint: William Morrow Paperbacks
- On Sale: 04/19/2011
- Trimsize: 5.313 in (w) x 8 in (h) x 0.649 in (d)
- Pages: 288
- List Price: 14.99 USD
- BISAC1: BODY, MIND & SPIRIT / Supernatural


text:
ODI - Java Table Function for PDF capture
By David Allan-Oracle on Jan 16, 2013
You can leverage the java table function approach to easily integrate PDF using an API like iText. I blogged earlier about the approach of writing a specific LKM for this, although this is perfectly reasonable, the writing and subsequent maintenance of the KM especially if you have many such APIs can be simplified, the code is also much cleaner in my opinion. What do you think? Its simplified by using the LKM for a java table function I posted here, then writing specific table functions for adapters.
All I did was write the table function wrapper and the makeRow method - this can even support the convention for naming columns from the earlier PDF blog post by overloading the findColumn method (so the query will use COLUMN_n, such as COLUMN_2 - under the hood, we will get the number n and return the appropriate column).
The makeRow method produces the columns from a java Object, the object is a File object, and represents the PDF file, here is a snippet of the code;
- public String[] makeRow(Object obj) throws SQLException
- {
- String[] row = null;
- int i = 0;
- try {
- PdfReader reader = new PdfReader(((File)obj).getPath());
- Iterator it = reader.getAcroFields().getFields().entrySet().iterator();
- row = new String[ reader.getAcroFields().getFields().size() ];
- while (it.hasNext())
- row[i++] = reader.getAcroFields().getField(((Map.Entry)it.next()).getKey().toString()).toString();
- reader.close();
- } catch (Exception e) { e.printStackTrace(); }
- return row;
- }
The code is very simple, for the table function itself, I simply created a Java Iterator (line 19 below) over the array of files in the directory, the class I extended from conveniently takes care of the iteration.
- public static ResultSet readCollection(String dirName, String endstr)
- throws SQLException, UnknownHostException, IOException
- {
- final String suffix = endstr;
- File folder = new File( dirName );
- File[] listOfFiles = folder.listFiles(new FilenameFilter() {
- public boolean accept(File dir, String name) {
- return name.toLowerCase().endsWith(suffix);
- }
- } );
- ArrayList<File> al = new ArrayList<File>();
- for (int i = 0; i < listOfFiles.length; i++)
- al.add( listOfFiles[i] );
- PdfReader reader = new PdfReader(((File)listOfFiles[0]).getPath());
- int sz = reader.getAcroFields().getFields().entrySet().size();
- String[] cols = new String[sz];
- for (int j = 0; j < sz; j++)
- cols[j] = new String(new Integer(j+1).toString());
- return new pdf_table( cols, al.iterator() );
- }
The entire Java source for the PDF table function can be found here.
We can assign the LKM to the source set and set the table function name to pdf_table.readCollection, define the directory to use and the file extension to filter.
For this case using the table function I set the model type for the PDF datastore model to be my Derby/JavaDB technology (and not file). This generated the SQL SELECT........from table(PDF_W4('d:\temp\pdfs', 'pdf' )) PDF where (1=1) statement to load into the work table. This was using the exact LKM that I used to extract from MongoDB, and I can write any java table function to extract data and load.


text:
Get your skills to the NEXT LEVEL this summer! Sign up now with one of our four COLLEGE COACHES in pitching, fielding, hitting, or catching. Sessions are an hour long with only 4 players per coach. This is a great opportunity to get individual instruction by our expert coaches. Don't miss out! The NEXT LEVEL clinic will be held on July 8th and 9th at the PAL complex in Plainville, MA. Please e-mail email@example.com for flyer and application, or with any questions.
ACTIVE is the leader in online event registrations from 5k running races and marathons to softball leagues and local events. ACTIVE also makes it easy to learn and prepare for all the things you love to do with expert resources, training plans and fitness calculators.


text:
Apple to Turn on Location-Sensing iBeacon Service
Apple is planning today to turn on its iBeacon location service at all 254 of its stores in the U.S., the Associated Press reported.
Apple confirmed the report, saying it is excited about what iOS developers will be able to do with "micro-location awareness" for things like museum exhibits and park-trail markers.
The technology uses a version of Bluetooth, a form of wireless close-range communication, that senses when someone is nearby or in a store. Apple could send targeted coupons, messages, in-store directions or videos, among other uses. Apple has been mostly quiet about iBeacon, other than mentioning it during an earlier iOS 7 launch event. The technology came with the latest version of the mobile operating system. The AP writes:
The implications go beyond Apple stores. One day, commuters might get information on subway delays as they stand on the platform, while museum visitors might get details on the painting they are standing in front of. Other retailers, of course, will be also able to offer special deals or track which aisle shoppers spend the most time at.
Location-tracking technology like iBeacon and Near Field Communication, or NFC, is growing, despite concerns raised by privacy advocates. Retailers like the close-range tracking service because it provides a more accurate sense of location than GPS, which doesn't work well indoors.
Apple isn't the first company to deploy in-store tracking. Shopkick, a rewards app, already has placed transmitters in Macy's department stores in San Francisco and New York. Major League Baseball is planning to use iBeacon technology in some stadiums. For iBeacon to work in Apple stores, customers must have Bluetooth enabled on their phones and download the Apple Store app.